What’s more, miR-182-5p inhibition can reduce the viability of MCF-7 (human breast cancer cell line) cells because of apoptosis induction, probably through the upregulation of CASP9 (Sharifi and Moridnia, 2017). Here, CASP9 is linked to breast cancer.